Enfuvirtide (Fuzeon) for HIV Infection.
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D004305:Dose-Response Relationship, Drug; D024882:Drug Resistance, Viral; D000077560:Enfuvirtide; D005252:Fees, Pharmaceutical; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide